Seeking Alpha

  Progenics Pharmaceuticals Inc. (PGNX) - NASDAQ

  • StockConsultant | Send Message 13 Jan

    $PGNX nice breakout above important 6.38 triple+ resistance level,
      PGNX vs. ETF Alternatives
      Company Description
      Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology .It develops products for the treatment of prostate cancer, for the treatment of opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States